{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:19:38Z","timestamp":1760955578026},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,5]],"date-time":"2015-08-05T00:00:00Z","timestamp":1438732800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12883-015-0371-8","type":"journal-article","created":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T10:33:39Z","timestamp":1438684419000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany \u2013 results from the German AFNET registry"],"prefix":"10.1186","volume":"15","author":[{"name":"on behalf of the AFNET registry investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl Georg","family":"Haeusler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Gerth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Limbourg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Tebbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Oeff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Wegscheider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e1s","family":"Treszl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Ravens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Meinertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnter","family":"Breithardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Steinbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Nabauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,5]]},"reference":[{"key":"371_CR1","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1093\/europace\/eur416","volume":"14","author":"AJ Camm","year":"2012","unstructured":"Camm AJ, Lip GYH, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation\u2013developed with the special contribution of the European Heart Rhythm Association. Europace. 2012;14:1385\u2013413.","journal-title":"Europace"},{"key":"371_CR2","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/europace\/eus333","volume":"15","author":"T Wilke","year":"2013","unstructured":"Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R, et al. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Europace. 2013;15:486\u201393.","journal-title":"Europace"},{"key":"371_CR3","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1161\/01.STR.0000166053.83476.4a","volume":"36","author":"C Marini","year":"2005","unstructured":"Marini C, De Santis F, Sacco S, Russo T, Olivieri L, Totaro R, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke. 2005;36:1115\u20139.","journal-title":"Stroke"},{"key":"371_CR4","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/eurheartj\/ehn101","volume":"29","author":"R Nieuwlaat","year":"2008","unstructured":"Nieuwlaat R, Dinh T, Olsson SB, Camm AJ, Capucci A, Tieleman RG, et al. Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? Eur Hear J. 2008;29:915\u201322.","journal-title":"Eur Hear J"},{"key":"371_CR5","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1093\/eurheartj\/ehs446","volume":"34","author":"P Kirchhof","year":"2013","unstructured":"Kirchhof P, Curtis AB, Skanes AC, Gillis AM, Samuel Wann L, John CA. Atrial fibrillation guidelines across the Atlantic: a comparison of the current recommendations of the European Society of Cardiology\/European Heart Rhythm Association\/European Association of Cardiothoracic Surgeons, the American College of Cardiology Fou. Eur Hear J. 2013;34:1471\u20134.","journal-title":"Eur Hear J"},{"key":"371_CR6","doi-asserted-by":"crossref","unstructured":"Endres, M, Diener, H RJ. Sekund\u00e4rprophylaxe Des Isch\u00e4mischen Insults. 5th edition. Stuttgart; 2012:324\u201347","DOI":"10.1055\/b-0034-37806"},{"key":"371_CR7","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1365-2125.2004.02086.x","volume":"57","author":"D Deplanque","year":"2004","unstructured":"Deplanque D, Leys D, Parnetti L, Schmidt R, Ferro J, De Reuck J, et al. Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study. Br J Clin Pharmacol. 2004;57:798\u2013806.","journal-title":"Br J Clin Pharmacol"},{"key":"371_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ahj.2012.10.010","volume":"165","author":"MP Turakhia","year":"2013","unstructured":"Turakhia MP, Hoang DD, Xu X, Frayne S, Schmitt S, Yang F, et al. Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective Evaluation and Assessment of Therapies in AF (TREAT-AF) study. Am Heart J. 2013;165:93\u2013101.e1.","journal-title":"Am Heart J"},{"key":"371_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.amjopharm.2009.06.002","volume":"7","author":"LG Jacobs","year":"2009","unstructured":"Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and\/or early-stage dementia: a single-center, retrospective, observational study. Am J Geriatr Pharmacother. 2009;7:159\u201366.","journal-title":"Am J Geriatr Pharmacother"},{"key":"371_CR10","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00392-011-0320-5","volume":"100","author":"T Meinertz","year":"2011","unstructured":"Meinertz T, Kirch W, Rosin L, Pittrow D, Willich SN, Kirchhof P. Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry. Clin Res Cardiol. 2011;100:897\u2013905.","journal-title":"Clin Res Cardiol"},{"key":"371_CR11","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/j.1747-4949.2011.00672.x","volume":"7","author":"KG Haeusler","year":"2012","unstructured":"Haeusler KG, Konieczny M, Endres M, Villringer A, Heuschmann PU. Impact of anticoagulation before stroke on stroke severity and long-term survival. Int J Stroke. 2012;7:544\u201350.","journal-title":"Int J Stroke"},{"key":"371_CR12","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1160\/TH11-02-0070","volume":"105","author":"P Kirchhof","year":"2011","unstructured":"Kirchhof P, Nabauer M, Gerth A, Limbourg T, Lewalter T, Goette A, et al. Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions. Thromb Haemost. 2011;105:1010\u201323.","journal-title":"Thromb Haemost"},{"key":"371_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/europace\/eun369","volume":"11","author":"M Nabauer","year":"2009","unstructured":"Nabauer M, Gerth A, Limbourg T, Schneider S, Oeff M, Kirchhof P, et al. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace. 2009;11:423\u201334.","journal-title":"Europace"},{"key":"371_CR14","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/europace\/eul097","volume":"8","author":"V Fuster","year":"2006","unstructured":"Fuster V, Ryd\u00e9n LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee. Europace. 2006;8:651\u2013745.","journal-title":"Europace"},{"key":"371_CR15","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/circ.104.17.2118","volume":"104","author":"V Fuster","year":"2001","unstructured":"Fuster V, Ryd\u00e9n LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC\/AHA\/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee. Circulation. 2001;104:2118\u201350.","journal-title":"Circulation"},{"key":"371_CR16","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1160\/TH11-11-0768","volume":"107","author":"T Wilke","year":"2012","unstructured":"Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R, et al. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients. Thromb Haemost. 2012;107:1053\u201365.","journal-title":"Thromb Haemost"},{"key":"371_CR17","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1378\/chest.10-2436","volume":"140","author":"L Gorin","year":"2011","unstructured":"Gorin L, Fauchier L, Nonin E, Charbonnier B, Babuty D, Lip GYH. Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project. Chest. 2011;140:911\u20137.","journal-title":"Chest"},{"key":"371_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/europace\/eut263","volume":"16","author":"P Kirchhof","year":"2014","unstructured":"Kirchhof P, Ammentorp B, Darius H, De Caterina R, Le Heuzey J-Y, Schilling RJ, et al. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF). Europace. 2014;16:6\u201314.","journal-title":"Europace"},{"key":"371_CR19","doi-asserted-by":"publisher","unstructured":"Lip GYH, Laroche C, Ioachim PM, Rasmussen LH, Vitali-Serdoz L, Petrescu L, Darabantiu D, Crijns HJGM, Kirchhof P, Vardas P, Tavazzi L, Maggioni AP, Boriani G. Prognosis and treatment of atrial fibrillation patients by European cardiologists: One Year Follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry). Eur Hear J.; Epub ahead:31 Aug 2014. doi: 10.1093\/eurheartj\/ehu374 .","DOI":"10.1093\/eurheartj\/ehu374"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-015-0371-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0371-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0371-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0371-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T23:09:05Z","timestamp":1653001745000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-015-0371-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,5]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["371"],"URL":"https:\/\/doi.org\/10.1186\/s12883-015-0371-8","relation":{},"ISSN":["1471-2377"],"issn-type":[{"type":"electronic","value":"1471-2377"}],"subject":[],"published":{"date-parts":[[2015,8,5]]},"assertion":[{"value":"17 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"129"}}